New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Universal Health Realty Income Trust

UHT

Real Estate Reit Healthcare Facilities

Universal Health Realty Income Trust’s revenue for fiscal 2025 (year ended December 2025) was $99.2 million, roughly unchanged from fiscal 2024.

Revenue
+0.17%
EPS
+20.7%
Free cash flow
n/m
Total debt
+5.35%

Quarter to September 2026, against a year earlier

37.28 0.12 +0.32%

After hours trading: 37.22, down 0.16%, last trade Fri 4:01pm Eastern.

Market cap
$516.5M
P/E
25.5×
Fwd P/E FY26e
31.2×
Dividend yield
8.02%
F-score
4/9
ROIC
4.21%
Net debt / EBITDA
5.7×
Payout ratio
2.1×

Ratios over time FY16 to FY25

Returns on capital

ROIC was 4.18% in FY25, against a low of 2.75% in FY16. ROE, at 10.6%, is far above it because equity is small against the capital the business uses.

ROEROIC
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
ROE8.9%22.7%11.8%10.0%11.4%55.4%9.1%7.2%10.1%10.6%
ROIC2.8%3.2%3.7%3.6%3.6%3.3%3.4%3.6%4.2%4.2%

Debt

Net debt is 5.73× a year’s EBITDA. Debt is 2.46× equity.

Debt / equityNet debt / EBITDA
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Debt / equity1.7×1.2×1.3×1.5×1.9×1.4×1.5×1.8×2.1×2.5×
Net debt / EBITDA6.9×5.2×4.9×5.1×5.6×5.4×5.8×5.9×5.6×5.7×

Per share, from FY16

Since FY16, per share: free cash flow has grown 3.20% a year; revenue has grown 4.14% a year; book value has fallen 2.78% a year.

Free cash flowRevenueBook value
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Free cash flow1.0×1.0×1.2×1.0×0.7×0.7×0.8×0.9×1.3×1.3×
Revenue1.0×1.1×1.1×1.1×1.1×1.2×1.3×1.4×1.4×1.4×
Book value1.0×1.1×1.0×0.9×0.8×1.2×1.2×1.0×0.9×0.8×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
3 7 5 5 5 5 4 5 7 4
P/E ratio
51.25 22.02 34.87 84.43 45.58 7.49 31.42 39.56 26.77 30.63
P/S ratio
13.17 13.89 11.05 20.89 11.32 9.72 7.30 6.33 5.19 5.46
P/FCF ratio
29.91 32.75 24.29 53.13 43.71 40.07 27.22 22.13 13.57 13.46
P/Operating CF
80.43 81.20 86.93 147.57 77.24 70.95 53.87 57.90 39.05 39.86
P/B ratio
4.62 4.77 4.24 8.87 5.55 3.48 2.89 3.01 2.86 3.56
EV/Sales
17.81 17.39 14.41 24.35 15.03 13.36 11.00 10.01 8.83 9.17
EV/EBITDA
26.62 25.68 21.10 36.13 22.50 19.76 17.27 16.04 13.50 14.17
EV/FCF
40.47 40.99 31.69 61.95 58.03 55.07 41.00 34.97 23.12 22.60
Current Ratio
0.93 0.98 1.25 1.26 0.82 8.39 7.93 6.54 8.07 6.05
Net Debt/EBITDA
6.94 5.16 4.92 5.15 5.55 5.38 5.81 5.89 5.57 5.73
Debt/Equity
1.65 1.22 1.32 1.51 1.86 1.40 1.50 1.79 2.05 2.46
ROE
8.91% 22.71% 11.83% 9.97% 11.41% 55.37% 9.09% 7.16% 10.11% 10.61%
ROA
3.50% 8.99% 4.97% 3.90% 3.96% 19.99% 3.50% 2.56% 3.27% 3.07%
ROIC
2.75% 3.24% 3.67% 3.58% 3.62% 3.33% 3.40% 3.55% 4.25% 4.18%
Return on Tangible Assets
3.86% 10.22% 5.49% 4.35% 4.42% 20.57% 3.90% 2.95% 3.81% 3.64%
Average Days of Receivables
41.42 45.92 48.89 50.15 50.08 357.41 392.43 318.04 305.23 302.29
Earnings Yield
1.95% 4.54% 2.87% 1.18% 2.19% 13.35% 3.18% 2.53% 3.74% 3.26%
Free Cash Flow Yield
3.34% 3.05% 4.12% 1.88% 2.29% 2.50% 3.67% 4.52% 7.37% 7.43%
Free Cash Flow per Share
2.19 2.25 2.53 2.21 1.47 1.48 1.77 1.98 2.74 2.91
Book value per Share
14.21 15.45 14.47 13.23 11.57 17.11 16.64 14.58 13.01 11.03
Free Cash Flow
29.53 30.69 34.67 30.33 20.21 20.42 24.32 27.36 37.84 40.26
EV/EBIT
54.04 52.34 41.13 72.98 45.09 38.95 32.52 30.51 23.77 26.17
Other line items

Show all line items

Columns are period end dates · fundamentals updated Nov 17, 2026